Motus GI Medical Technologies is a biotechnology and medical devices company founded in 2010 and headquartered in the United States. The company's flagship product, the Pure-Vu® System, aims to enhance endoscopy procedures, improve visualization, and assist in emergent GI procedures. The Pure-Vu® System, cleared by the U.S. Food and Drug Administration through a 510(k) clearance, has also obtained CE mark approval in Europe. Recently, the company secured a $12.00M Post-IPO Debt investment on 21 July 2021, with Kreos Capital participating as the investor. Motus GI Medical Technologies is dedicated to advancing endoscopy outcomes, reducing costs, and improving patient experiences in the field of gastroenterology.
Motus GI Medical Technologies
Pure-Vu improves visualization for a high-quality endoscopy the first time.
Founded 2010
Fort Lauderdale, United States
23 employees
Post-IPO Debt
Total: $50.00M
Biotechnology, Health Care +2
Fort Lauderdale, United States
23 employees
Post-IPO Debt
Total: $50.00M
Biotechnology, Health Care +2
General Information
Company Name
Motus GI Medical Technologies
Founded Year
2010
Location
Fort Lauderdale, United States
Fort Lauderdale, United States
Employees
23
Industries
Biotechnology, Health Care, Information Technology +1
Funding Stage
Post-IPO Debt
BounceWatch is an independent company data service, not affiliated with Motus GI Medical Technologies. To contact Motus GI Medical Technologies, visit motusgi.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Motus GI Medical Technologies compare?
A PDF of Motus GI Medical Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Motus GI Medical Technologies soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About Motus GI Medical Technologies
Business keywords: Gastroenterology, Endoscopy, Colorectal Cancer, GI Tract Disease Detection, Medical Technology, FDA Cleared, CE Mark Approval, Healthcare Innovation, Patient Experience Enhancement, Procedure Optimization, Colonoscopy Improvement, Health Technology, Disease Prevention, Emergent Procedure Assistance
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Debt | $12.00M | 1 |
|
21 Jul 2021 |
| Post IPO Debt | $8.00M | 1 |
Silicon Valley Bank
|
18 Dec 2019 |
| Venture Round | $30.00M | 6 |
|
01 Dec 2016 |
Motus GI Medical Technologies Alternatives & Competitors
View All Alternatives
Motus GI Medical Technologies vs
EndoVigilant
United States
AI enabled Medical Imaging Platform for Endoscopy Procedures
2 employees
AI, Health Care
Motus GI Medical Technologies vs
诺辉健康 New Horizon Health Limited
Cayman Islands
業務概覽 我們的願景是通過篩查及早期檢測預防及治愈癌症。我們旨在推進技術創新，并加速癌症篩查技術於中...
Series E
12 employees
Big Data, Biotechnology
Motus GI Medical Technologies vs
OutSense
Israel
An advanced medical IoT platform capable of analyzing and diagnosing human waste from within a stand...
Series A
23 employees
Biotechnology, Health Care
FAQ About Motus GI Medical Technologies
Pure-Vu improves visualization for a high-quality endoscopy the first time.
Motus GI Medical Technologies was founded in 2010.
Motus GI Medical Technologies is headquartered in Fort Lauderdale, United States.
Motus GI Medical Technologies operates in Biotechnology, Health Care, Information Technology and Medical Devices. Its work centres on Gastroenterology, Endoscopy, Colorectal Cancer and GI Tract Disease Detection.
Motus GI Medical Technologies has approximately 23 employees.
Motus GI Medical Technologies has completed 3 funding rounds, raising a total of $50.00M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Motus GI Medical Technologies include EndoVigilant, 诺辉健康 New Horizon Health Limited, OutSense, Cyted Health, Novian Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Motus GI Medical Technologies and EndoVigilant are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Motus GI Medical Technologies, https://bouncewatch.com/company/motus-gi, updated 3 March 2025. When citing, please name BounceWatch and link this page.
